Abstract
During routine cardiac catheterization of ten patients with ventricular septal defect, the hemodynamic parameters were measured in the resting state and during sodium nitroprusside infusion at an average rate of 8 μg/kg/min. Two distinct hemodynamic groups could be identified. Group I characterised by elevated left ventricular filling pressure showed a consistently favourable response to sodium nitroprusside infusion with a decrease in the left ventricular filling pressure, the pulmonary arterial pressures and the left to right shunt. The favourable effect was most pronounced in patients who had pulmonary arterial hypertension in addition to elevated left ventricular filling pressures. Group II patients characterised by normal left ventricular filling pressures showed a variable response to sodium nitroprusside administration. The left ventricular end-diastolic pressure fell or was unaltered. The pulmonary arterial pressures and pulmonary vascular resistance fell in those with pulmonary arterial hypertension. Patients without pulmonary arterial hypertension showed an increase in the magnitude of left to right shunt. On the basis of our data, we feel that vasodilator drugs have a specific role in the management of congestive heart failure secondary to large left to right shunts. The present study strongly indicates the need for further investigations utilizing orally effective vasodilators in patients with congestive heart failure due to left to right shunts.
Similar content being viewed by others
References
Chatterjee K, Parmley WW, Ganz W, Forrester J, Walinsky P, Crexells C, Swan HJC (1973) Haemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48:1183–1193
Guiha NH, Cohn JN, Mikulic E, Franciosa JA, Limas CJ (1974) Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 291:587–592
Kasliwal RS, Manchanda SC, Bhatia ML, Wasir HS (1980) Hemodynamic effects of trinitroglycerin in aortic and mitral valve disease. Ind Heart J 32:30–36
Knappe E, Gmeiner R (1977) Reduction of pulmonary hypertension by nitroprusside. Int J Clin Pharmacol and Biopharm 15:75–80
LaFarge CG, Miettinen OS (1970) The estimation of oxygen consumption. Cardiovasc Res 4:23–30
Lukes SA, Romera CA Jr, Resnekov L (1979) Haemodynamic effects of sodium nitroprusside in 21 subjects with congestive heart failure. Br Heart J 41:187–191
Majid PA, Sharma B, Taylor SH (1971) Phentolamine for vasodilator treatment of severe heart failure. Lancet 2:719–724
Miller RR, Vismara LA, Zelis R, Amsterdam EA, Mason DT (1975) Clinical use of sodium nitroprusside in chronic ischaemic heart disease. Circulation 51:328–336
Palmer RF, Lasseter KC (1975) Sodium nitroprusside. N Engl J Med 292:294–297
Rubin LJ, Peter RH (1980) Oral hydralazine therapy for primary pulmonary hyptertension. N Engl J Med 302:69–73
Stephenson LW, Edmunds LH Jr, Raphaely R, Morrison DF, Hoffman WS, Rubis LJ (1979) Effects of nitroprusside and dopamine on pulmonary arterial vasculature in children after cardiac surgery. Circulation (Suppl I):104–110
Synhorst DP, Lauer RM, Doty DB, Brody MJ (1976) Haemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects. Circulation 54:473–477
Tecklenburg PL, Fitzgerald S, Allaire BI, Alderman EL, Harrison DC (1976) Afterload reduction in the management of postinfarction ventricular septal defects. Am J Cardiol 38:956–958
Vogelpoel L, Nellen M, Swanepoel A, Schrire V (1959) The use of amylnitrite in the diagnosis of systolic murmurs. Lancet 2:810–817
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Subramanyam, R., Tandon, R. & Shrivastava, S. Hemodynamic effects of sodium nitroprusside in patients with ventricular septal defect. Eur J Pediatr 138, 307–310 (1982). https://doi.org/10.1007/BF00442503
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442503